R C Jackson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

R C Jackson

Showing results (131-140 of 132) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 132 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995

Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusionI Rafi, G A Taylor, J A Calvete, et al.

Journal of Medicinal Chemistry|January 1, 1987

Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemiasH D Showalter, J L Johnson, J M Hoftiezer, et al.

Pageof 14

Search research articles

Showing results (131-140 of 132) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 132 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995

Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusionI Rafi, G A Taylor, J A Calvete, et al.

Journal of Medicinal Chemistry|January 1, 1987

Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemiasH D Showalter, J L Johnson, J M Hoftiezer, et al.

Pageof 14